08
Feb
<
An investigation by the University of Navarra has identified a protein that could act as a diagnostic marker for lung cancer, in Navarre cause 18% of deaths from tumor.
Pamplona scientist Igor Hernández, has defended his doctoral thesis under the name ADAM8-Delta 14, is a molecule that is only detected in lung cancer cells and is used by them to activate the mechanism of bone degradation favoring metastasis and tissue destruction, as reported by the university in a statement.
The researcher of the Center for Applied Medical Research (CIMA), has insisted that "early diagnosis is critical of the disease as lung cancer is the leading cause of cancer deaths in Europe due to a generally late diagnosis, when has already begun to metastasize, most
often localized in the brain and bone marrow.
In the latter case, the specialist, who will present his analysis in two international conferences in Canada, stressed that patients' suffer intense pain, bone fractures and severe metabolic disorders.
Their work continues now with the definition of the new molecule as a diagnostic marker, which will be necessary to observe its expression in different types of lung tumors with different levels of development while at the same time explore the expression of the protein in other types cancer.
Leave a Reply